Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Abbott/Nihon Kohden partner in haematology:

This article was originally published in Clinica

Executive Summary

Nihon Kohden and Abbott have entered into an agreement to commercialise automated haematology diagnostic instruments manufactured by Nihon Kohden of Tokyo, Japan. The products will be distributed exclusively by Abbott under the CELL-DYN Pearl brand name in the US and Canada. The Abbott Park, Illinois company also has non-exclusive distribution rights in all other markets apart from China and Japan. Harold Flynn, divisional vice-president and general manager of Abbott Hematology, said that the new agreement provided an opportunity to expand Abbott's instrument offering for smaller hospitals, large clinics and physician offices.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT054339

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel